Recent research highlights herbal treatments for dementia as potentially valuable options for managing the symptoms of Alzheimer’s disease. Given the clinical challenges and side effects associated with standard medications, many physicians and researchers are exploring phytopharmaceuticals as complementary therapies. A comprehensive systematic review recently analyzed 48 human trials to evaluate the efficacy and safety of these botanical interventions.

Clinical Efficacy of Herbal Treatments for Dementia

The review identified significant cognitive improvements following the administration of Ginkgo biloba and Crocus sativus (Saffron). Furthermore, some herbal formulations demonstrated symptomatic efficacy comparable to donepezil, a gold-standard acetylcholinesterase inhibitor. These findings suggest that specific plant-based extracts could play a significant role in managing cognitive decline. For instance, the neuroprotective properties of these herbs may help mitigate oxidative stress and improve blood flow within the cerebral environment. However, researchers emphasize that while short-term symptomatic effects are promising, the evidence remains insufficient to claim superiority over conventional drugs.

Safety and Role as Complementary Care

Safety profiles for most reviewed phytopharmaceuticals appeared favorable compared to standard allopathic treatments. Consequently, these options are particularly relevant for patients who experience contraindications or poor tolerability with current medications. Nevertheless, many studies are limited by small sample sizes and brief intervention periods, often lasting only three to six months. This duration is too short to determine if these herbal treatments for dementia function as disease-modifying treatments (DMTs). Therefore, long-term research is essential to confirm whether these therapies can truly alter the underlying pathology of neurodegeneration.

Frequently Asked Questions

How do herbal treatments compare to standard drugs like donepezil?

Clinical trials indicate that certain extracts, such as Ginkgo biloba, may offer symptomatic benefits similar to donepezil in the short term. However, more robust data are required to prove they are equally effective for long-term management.

Which herbs showed the most promise in clinical trials?

The systematic review highlighted Ginkgo biloba and Crocus sativus (Saffron) as the most effective herbal interventions for improving cognitive outcomes in dementia patients.

Can herbal therapies stop the progression of Alzheimer’s disease?

Current evidence suggests these treatments primarily offer symptomatic relief. There is no definitive data yet to classify them as disease-modifying treatments that can stop or reverse the progression of Alzheimer’s.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Kaczmarek-Kryszak KA et al. A comprehensive systematic review of human trials investigating herbal treatments for Alzheimer's disease and dementia. Acta Neuropsychiatr. 2026 May 08. doi: 10.1017/neu.2026.10085. PMID: 42100836.

Georgetown University School of Medicine. Study Finds No Evidence of Benefit for Ginkgo Biloba in Cognitive Impairment; Possible Benefit in Dementia. Cochrane Database Syst Rev. 2026 Feb 05. doi: 10.1002/14651858.CD013661.pub2.

Hasanat A et al. Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review. MDPI. 2025 Feb 19. doi: 10.3390/pharmaceutics17020214.